Sven Pålhagen - Concepedia

Author

Sven Pålhagen

Also Known As

Martin Paucar, Pålhagen, Sven, S Palhagen, S Pålhagen, S. E. Pålhagen, S. Palhagen, S. Pålhagen, S. Pâlhagen, S. Pålhagen, S.-E. Pålhagen

Publications

1.9K

Citations

H-Index

Concepts

All Affiliations

Karolinska University Hospital Karolinska Institutet Uppsala University Linköping University Skåne University Hospital

About

Sven Pålhagen is an author at Karolinska University Hospital specializing in medicine, neurology, and neuropharmacology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	7	7	499
2	Social Sciences	3	3	202
3	Health Sciences	1	1	104
4	Public Health	1	1	51
5	Environmental Health	1	1	51

Sven Pålhagen

Publications

1.8K

Citations

H-Index

Page 1

	Year	Citations
Selegiline slows the progression of the symptoms of Parkinson disease Sven Pålhagen, E. H. Heinonen, J. Hägglund, Neurology	2006	265
Euro<scp>I</scp>nf: <scp>A</scp><scp>M</scp>ulticenter <scp>C</scp>omparative <scp>O</scp>bservational <scp>S</scp>tudy of <scp>A</scp>pomorphine and <scp>L</scp>evodopa <scp>I</scp>nfusion in <scp>P</scp>arkinson's <scp>D</scp>isease Pablo Martínez‐Martín, Prashanth Reddy, Regina Katzenschlager, Movement Disorders	2014	240
Selegiline delays the onset of disability in de novo parkinsonian patients Sven Pålhagen, E. H. Heinonen, J. Hägglund, Neurology	1998	148
Factors of importance for weight loss in elderly patients with Parkinson's disease Birgitta Lorefält, W. Ganowiak, Sven Pålhagen, Acta Neurologica Scandinavica	2004	128
Rufinamide: a double-blind, placebo-controlled proof of principle trial in patients with epilepsy Sven Pålhagen, R. Canger, Olaf Henriksen, Epilepsy Research PsychiatryPrinciple TrialPsychotropic MedicationNeuropharmacologyPharmacotherapy	2001	127
Oxysterols and Parkinson's disease: Evidence that levels of 24S-hydroxycholesterol in cerebrospinal fluid correlates with the duration of the disease Ingemar Björkhem, Anita Lövgren‐Sandblom, Valerio Leoni, Neuroscience Letters Cerebrospinal Fluid CorrelatesOxysterolNeurophysiologyMedicineCerebrospinal Fluid	2013	105
Safety and tolerability of intracerebroventricular PDGF-BB in Parkinson’s disease patients Gesine Paul, Olof Zachrisson, Andrea Varrone, Journal of Clinical Investigation Clinical NeurologyClinical NeurosciencePharmacotherapyDat BindingTranslational Medicine	2015	104
Monoamines, BDNF, IL-6 and corticosterone in CSF in patients with Parkinson’s disease and major depression Sven Pålhagen, Hongshi Qi, Björn Mårtensson, Journal of Neurology PsychoneuroimmunologyNeurobiology Of DiseasePsychiatryMedicinePsychotropic Medication	2009	74
Does l-dopa treatment contribute to reduction in body weight in elderly patients with Parkinson's disease? Sven Pålhagen, Birgitta Lorefält, Maine Carlsson, Acta Neurologica Scandinavica	2004	66
Interim analysis of long-term intraduodenal levodopa infusion in advanced Parkinson disease Sven Pålhagen, Nil Dizdar, Tove Hauge, Acta Neurologica Scandinavica	2012	63

Page 1